* A lab-designed protein mimicking both insulin and glucagon has shown promising results for controlling blood sugar in Type 1 diabetes * The formulation may not require refrigeration, making ...

Retatrutide (LY3437943) is an agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and glucagon receptors. Its dose–response relationships with respect to side effects ...

A new animal study suggests that in the future it might be possible for millions of people who have type 1 diabetes to better control their disease by regenerate their own insulin-producing capacity.

Discover how eating too few carbs can influence hormones that affect energy, appetite, metabolism, mood, and menstrual cycles ...

Research shows that the biological parents' genes affect the child's insulin function and capacity to regulate blood sugar levels and blood lipids in different ways. Such knowledge may be used to to ...

The new drugs could become the way forward for medicated weight loss as clinical trials reveal optimistic results ...

Severe hypoglycemia (low blood sugar) can cause people with diabetes to have seizures or lose consciousness, which can make it impossible to treat low blood sugar by eating or drinking something ...

Explore scalable strategies for iPSC-derived islet differentiation using GMP-grade activin A and KGF to advance diabetes ...

Short-term IF boosts glucose homeostasis, but prolonged fasting in adolescence may impair β cell maturation—potentially linking chronic IF to type 1 diabetes risk. Study: Chronic intermittent fasting ...